J R Thornton

Title: J R Thornton: Innovator in Dermatological Treatments

Introduction

J R Thornton is a notable inventor based in Leeds, GB. He has made significant contributions to the field of dermatology through his innovative methods of treatment. His work focuses on addressing pruritus, a condition that causes intense itching, which can be both antigen-induced and disease-induced.

Latest Patents

J R Thornton holds a patent for a method of treating pruritus with nalmefene and clonidine. This method involves orally administering nalmefene, a narcotic antagonist, to a mammal suffering from pruritus. The treatment begins with a dosage of about 1 to 25 mg for an initial period of 1 to 7 days. The dosage is then gradually increased by increments of 1 to 25 mg per day during successive periods of 1 to 7 days, reaching a maximum of 150 mg per day. Clonidine or clonidine hydrochloride may be administered alongside nalmefene to alleviate any opioid withdrawal symptoms.

Career Highlights

J R Thornton is associated with Baker Cumins Dermatologicals, Inc., where he continues to develop and refine his innovative treatment methods. His dedication to improving patient care in dermatology is evident through his research and patent contributions.

Collaborations

J R Thornton collaborates with Ronald R Tuttle, working together to advance their research and develop effective treatments for dermatological conditions.

Conclusion

J R Thornton's innovative approach to treating pruritus showcases his commitment to enhancing dermatological care. His patent reflects a significant advancement in the treatment of this challenging condition.